首页 | 本学科首页   官方微博 | 高级检索  
     

圣和散逆转胃癌SGC7901/VCR细胞多药耐药的研究
引用本文:夏跃胜,王建华,吴永忠,王欢. 圣和散逆转胃癌SGC7901/VCR细胞多药耐药的研究[J]. 中医杂志, 2006, 47(6): 459-460
作者姓名:夏跃胜  王建华  吴永忠  王欢
作者单位:1. 永济市肝胆胃病医院,山西省永济市中山东街39号,044500
2. 中国人民解放军第四军医大学唐都医院
3. 山西中医学院
摘    要:目的探讨中药圣和散逆转胃癌耐药细胞SGC7901/VCR多药耐药的机制。方法圣和散(浓度2.5、5和10mg/ml)处理胃癌耐药细胞SGC7901/VCR,用流式细胞技术检测P-糖蛋白(P-gp)表达,免疫组织化学SABC法及图像分析技术检测B细胞淋巴瘤/白血病基因-2(Bcl-2)。结果实验组SGC7901/VCR细胞Bcl-2表达A值(121.34±0.16)明显高于对照组(104.37±0.089)(P<0.05),Bcl-2表达减少,P-gp表达也明显降低。结论圣和散能逆转胃癌耐药细胞SGC7901/VCR多药耐药,其作用可能与调节Bcl-2和P-gp表达有关。

关 键 词:胃肿瘤/中医药疗法  抗药性,多药/中医药疗法  @圣和散
收稿时间:2005-06-14
修稿时间:2005-06-142005-11-10

Study on Shenghe Powder for Reversion of Multidrug Resistance of SGC7901/VCR Cells of Gastric Cancer
Xia Yuesheng,Wang Jianhua,Wu Yongzhong,et al.. Study on Shenghe Powder for Reversion of Multidrug Resistance of SGC7901/VCR Cells of Gastric Cancer[J]. Journal of Traditional Chinese Medicine, 2006, 47(6): 459-460
Authors:Xia Yuesheng  Wang Jianhua  Wu Yongzhong  et al.
Affiliation:Xia Yuesheng1,Wang Jianhua1,Wu Yongzhong2,et al.
Abstract:Objective:To explore the mechanism of Shenghe Powder(SHP) in reversion of multidrug resistence of SGC7901/VCR cells of gastric cancer.Methods:Gastric cancer drug-resistance cells SGC7901/VCR were treated with SHP at concentrations of 2.5,5.0 and 10mg/ml.The expression of P-glycoprotein(P-gp) was detected with flowcytometry and B-cell lymphoma/leukemia-2(Bcl-2) protein was examined by immunohistochemical SABC method and imaging analysis.Results:In SHP treated group,A value of Bcl-2 in SGC7901/VCR cells was significantly higher than that in the control group(P<0.05),and the expression of Bcl-2 and P-gp was significantly down-regulated.Conclusion:SHP can reverse the multidrug resistance of SGC7901/VCR,which is possibly related with the changes of the expressions of Bcl-2 and P-gp.
Keywords:Gastric tumor/TCM therapy   Resistance,multidrug/TCM therapy   @ Shenghe Powder
本文献已被 CNKI 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号